
Lariago 40mg Injection
Marketer
Ipca Laboratories Ltd
Salt Composition
Chloroquine (40mg)
Overview Lariago 40mg Injection
Malarex 40mg Injection combats malaria, preventing and treating infections. Its mechanism involves eliminating the malaria parasite, halting disease progression. Administration is strictly by a healthcare provider; self-injection is prohibited. Mosquito bite prevention is crucial: apply repellent to exposed skin, spray rooms to eliminate indoor mosquitoes, and wear light-colored, protective clothing after dusk. Potential side effects include weakness, nausea, vomiting, rash, itching, stomach upset, diarrhea, and loss of appetite. Injection site reactions (pain, swelling, redness) may occur. Persistent side effects warrant immediate medical attention. Diabetics should inform their doctor, as blood sugar levels may decrease, requiring regular monitoring. Blurred vision is possible; regular eye exams are advised during treatment. Long-term use may necessitate regular blood cell count monitoring. Report unexplained bruising, bleeding, sore throat, fever, or fatigue to your physician.
Primary Ingredients of Lariago 40mg Injection
The provided text is "undefined," which lacks meaning and cannot be rephrased.
Uses of Lariago 40mg Injection
Managing Malaria Infections
Major Benefits of Lariago 40mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Lariago 40mg Injection:
- Weakness
- Rash
- Headache
- Dizziness
- Vomiting
- Nausea
- Stomach pain
- Loss of appetite
- Diarrhea
How to use Lariago 40mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Lariago 40mg Injection works:
Malaria is effectively combatted by the antiparasitic Lariago 40mg Injection. Its mechanism involves elevating blood haem levels, a compound lethal to the malaria parasite, thus eradicating the infection.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between alcohol and Lariago 40mg Injection is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Lariago 40mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The 40mg Lariago injection poses minimal risk during lactation. Research in humans indicates negligible transfer of the medication into breast milk, presenting no apparent danger to the infant.
DrivingUNSAFE
Administration of Lariago 40mg Injection may induce adverse reactions impacting driving capabilities. These reactions can include blurred vision or impaired visual focus, potentially hindering safe operation of a vehicle.
KidneyCAUTION
Patients with impaired kidney function should use Lariago 40mg Injection cautiously. A modified dosage of Lariago 40mg Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Lariago 40mg Injection cautiously, potentially requiring a modified dosage. Physician consultation is recommended. Routine liver function monitoring during treatment may be prudent.
What if you forget to take Lariago 40mg Injection :
NA
Facts to Know About Lariago 40mg Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoquinoline derivative |
| Developing Habits | No. |
| Treatment Category | Ophthalmology |
| Actions | Aminoquinoline Antimalarials |
